Omsynth Lifesciences Pvt. Ltd. is one of the leading manufacturer and exporter of Axitinib. Axitinib is a potent, selective tyrosine kinase inhibitor (TKI) used primarily in the treatment of advanced renal cell carcinoma (RCC). It targets vascular endothelial growth factor receptors (VEGFR-1, -2, and -3), thereby inhibiting angiogenesis—the formation of new blood vessels that tumors need for growth and metastasis. Axitinib is administered orally and has a relatively short half-life, allowing for dose adjustments based on patient tolerance. It has demonstrated efficacy in patients who have failed prior systemic therapies for RCC. Common side effects include hypertension, diarrhea, fatigue, hand-foot syndrome, and decreased appetite. Axitinib may also cause proteinuria and thyroid dysfunction, requiring regular monitoring. It is considered a valuable option in targeted cancer therapy, especially in second-line settings. Buy high quality Axitinib from Omsynth Lifesciences.
